Invesco Discovery’s stable, experienced management team has achieved excellent long-term results with an approach that combines a willingness to pay high prices for fast growers with tactics that mitigate the risks.
Invesco Discovery Fund Class R6 ODIIX
- NAV / 1-Day Return $158.41 / +1.16 %
- Fund Size $7.4B
- Adjusted Expense Ratio 0.650%
- Net Expense Ratio 0.650%
- Fee Level: Distribution Low
- Share Class Type Retirement, Large
- Morningstar Category Small Growth
- Equity Style Box (Funds) Small Growth
- Minimum Initial Investment $1M
- Investment Status Limited
- TTM Yield 0.00%
- Turnover Ratio 87%
Morningstar’s Analysis ODIIX
Will ODIIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 20.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Ligand Pharmaceuticals Inc | 2.43 | 180M | Healthcare |
BrightSpring Health Services Inc | 2.34 | 173M | Healthcare |
JFrog Ltd Ordinary Shares | 2.30 | 171M | Technology |
Guardant Health Inc | 2.09 | 155M | Healthcare |
Repligen Corp | 2.00 | 148M | Healthcare |
Halozyme Therapeutics Inc | 1.99 | 147M | Healthcare |
Sanmina Corp | 1.90 | 141M | Technology |
Chord Energy Corp Ordinary Shares - New | 1.89 | 140M | Energy |
Enova International Inc | 1.84 | 137M | Financial Services |
WisdomTree Inc | 1.65 | 123M | Financial Services |